Although DCAF15 is a strong determinant for indisulam sensitivity as shown by us and others14,15, a recent study suggested that DCAF15 mRNA levels in primary samples of tumour cells of AML patients did not correlate to RBM39 degradation36. This evidence concerns the gene RBM39 and acute myeloid leukemia.